- Stachyose
-
- $0.00 / 1KG
-
2025-12-31
- CAS:54261-98-2
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 30tons/month
- Stachyose hydrate
-
- $50.00 / 100mg
-
2025-12-22
- CAS:54261-98-2
- Min. Order:
- Purity: 99.35%
- Supply Ability: 10g
- Stachyose
-
- $0.00 / 1kg
-
2025-06-13
- CAS:54261-98-2
- Min. Order: 1kg
- Purity: 60% 70% 80% 90%
- Supply Ability: 1000 kg
|
| | STACHYOSE Basic information |
| Product Name: | STACHYOSE | | Synonyms: | STACHYOSE N-HYDRATE;STACHYOSE;Lupeose, α-D-Gal-(1-6)-α-D-Gal-(1-6)-α-D-Glc-(1-2)-β-D-Fru, β-D-Fructofuranosyl-O-α-D-galactopyranosyl-(1-6)-O-α-D-galactopyranosyl-(1-6)-α-D-glucopyranoside;MANNOTETRAOSE;LUPEOSE;Stachyose hydrate,98.5%;beta-D-Fructofuranosyl O-alpha-D-Galactopyranosyl-(1-6)-O-alpha-D-galactopyranosyl-(1-6)-alpha-D-glucopyranoside
Lupeose
Manneotetrose;Stachyose hydrate, 97+% | | CAS: | 54261-98-2 | | MF: | C24H44O22 | | MW: | 684.59 | | EINECS: | 207-427-3 | | Product Categories: | | | Mol File: | 54261-98-2.mol |  |
| | STACHYOSE Chemical Properties |
| Melting point | 110 °C(dec.) | | storage temp. | -20°C | | Water Solubility | Soluble in water | | solubility | DMSO: 1 mg/ml,PBS (pH 7.2): 10 mg/ml | | form | Liquid | | color | Clear colorless to yellow to pale brown, may darken during storage | | biological source | plant (Stachys tuberifera) | | Optical Rotation | [α]24/D +133°, c = 4 in H2O | | BRN | 5710666 | | Stability: | Hygroscopic |
| Safety Statements | 22-24/25 | | WGK Germany | 3 | | HS Code | 29400090 |
| | STACHYOSE Usage And Synthesis |
| Uses | Stachyose Hydrate is a low molecular weight carbohydrate that was separated through an EM Gel OR-PVA column. | | Biological Activity | Stachyose belongs to the raffinose family of oligosaccharides (RFOs) | | in vivo | Stachyose hydrate (200, 400, 600 mg/kg, p.o., once daily for 3 weeks) alleviates colitis symptoms, restores intestinal barrier integrity, and modulates pro-inflammatory and anti-inflammatory cytokine expression in DSS (HY-116282C)-induced ulcerative colitis C57BL/6J mice[2]. | Animal Model: | DSS (HY-116282C)-induced ulcerative colitis C57BL/6J mouse model[2] | | Dosage: | 200, 400, 600 mg/kg | | Administration: | Oral gavage (p.o.), once daily for 3 weeks | | Result: | Significantly alleviated colitis symptoms in DSS-induced colitis mice, including reducing weight loss, lowering disease activity index (DAI), and increasing colon length, while restoring colonic epithelial barrier integrity.
Dose-dependently upregulated mRNA expression of ZO-1, Claudin-1, and Occludin, reduced IL-17, TNF-α, IL-1β, and IL-6 expression, and increased IL-10 levels. |
| | IC 50 | Human Endogenous Metabolite |
| | STACHYOSE Preparation Products And Raw materials |
|